Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy.

Shu, Runzhe; Hammett, Maree; Evtimov, Vera; Pupovac, Aleta; Nguyen, Nhu-Y; Islam, Rasa; Zhuang, Junli; Lee, Seyeong; Kang, Tae-Hun; Lee, Kyujun; Nisbet, Ian; Hudson, Peter; Lee, Jae Young; Boyd, Richard; Trounson, Alan

Shu, Runzhe; Hammett, Maree; Evtimov, Vera; Pupovac, Aleta; Nguyen, Nhu-Y; Islam, Rasa; Zhuang, Junli; Lee, Seyeong; Kang, Tae-Hun; Lee, Kyujun; Nisbet, Ian; Hudson, Peter; Lee, Jae Young; Boyd, Richard; Trounson, Alan.

Afiliação

Shu R; Cartherics Pty Ltd. Notting Hill Australia.
Hammett M; Australian Regenerative Medicine Institute Monash University Clayton Australia.
Evtimov V; Cartherics Pty Ltd. Notting Hill Australia.
Pupovac A; Australian Regenerative Medicine Institute Monash University Clayton Australia.
Nguyen NY; Cartherics Pty Ltd. Notting Hill Australia.
Islam R; Australian Regenerative Medicine Institute Monash University Clayton Australia.
Zhuang J; Cartherics Pty Ltd. Notting Hill Australia.
Lee S; Australian Regenerative Medicine Institute Monash University Clayton Australia.
Kang TH; Cartherics Pty Ltd. Notting Hill Australia.
Lee K; Australian Regenerative Medicine Institute Monash University Clayton Australia.
Nisbet I; Cartherics Pty Ltd. Notting Hill Australia.
Hudson P; Australian Regenerative Medicine Institute Monash University Clayton Australia.
Lee JY; Cartherics Pty Ltd. Notting Hill Australia.
Boyd R; Australian Regenerative Medicine Institute Monash University Clayton Australia.
Trounson A; ToolGen Inc. Seoul South Korea.